Imunon Inc (NASDAQ:IMNN)
| 1.62 Delayed Data As of 3:54pm ET |  +0.02 / +1.25%Today’s Change | 1.26 Today|||52-Week Range 7.68 | +20.00% Year-to-Date |
Latest IMNN News | Press Releases
No recent news for Imunon Inc.
Today’s Trading
| Previous close | 1.60 |
| Today’s open | 1.63 |
| Day’s range | 1.58 - 1.63 |
| Volume | 595 |
| Average volume (3 months) | 48,226 |
| Market cap | $11.4M |
Data as of 3:54pm ET, 02/02/2023
Growth & Valuation
| Earnings growth (last year) | -469.35% |
| Earnings growth (this year) | -8.70% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | 0.00% |
| P/E ratio | NM |
| Price/Sales | 5.86 |
| Price/Book | 0.01 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VBLTVascular Biogenics L... | -0.00 | -0.48% |
| APVOAptevo Therapeutics ... | -0.01 | -0.45% |
| QNRXQuoin Pharmaceutical... | +0.20 | +8.58% |
| NDRAENDRA Life Sciences ... | +0.10 | +2.44% |
Data as of 3:59pm ET, 02/02/2023
Financials
| Next reporting date | March 30, 2023 |
| EPS forecast (this quarter) | -$0.85 |
| Annual revenue (last year) | $500.0K |
| Annual profit (last year) | -$20.8M |
| Net profit margin | -4,153.85% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Lawrenceville, New Jersey |
Forecasts
